NCT04571333View on ClinicalTrials.gov

Feasibility of the Mi2000 Totally Implantable Cochlear Implant in Severely to Profoundly Deaf Adults.

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 7, 2020

Primary Completion Date

July 1, 2021

Study Completion Date

December 31, 2021

Conditions
Sensorineural Hearing Loss, BilateralCochlear Implants
Interventions
DEVICE

Mi2000 Totally Implantable Cochlear Implant

During the surgery visit, the Mi2000 Cochlear Implant will be implanted according to the general surgical guidelines and the Mi2000 specific surgical guidelines under general anaesthesia.

Trial Locations (2)

4000

Centre Hospitalier Universitaire de Liège, Department ORL, Liège

81377

Klinikum der Universität München, Campus Großhadern, München

All Listed Sponsors
lead

MED-EL Elektromedizinische Geräte GesmbH

INDUSTRY

NCT04571333 - Feasibility of the Mi2000 Totally Implantable Cochlear Implant in Severely to Profoundly Deaf Adults. | Biotech Hunter | Biotech Hunter